EVENTS · TRXB
PEERS
EARNINGS
No company news, with Biotechnology higher as a group
New 13D stake by ELI LILLY & Co. Across 5,146 earlier 13D campaigns, 4.7% of targets announced a sale within a year and 4.8% faced a proxy fight.
Insider lock-up ends on Nov 9, in 5 days (from the final prospectus); insiders can then trade their shares.
| Series | 1W | 1M |
|---|---|---|
| TRXB | −6.1% | — |
| Peers | +1.6% | +5.3% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 16 | — |
| Series | 1W | 1M |
|---|---|---|
| TRXB | −6.1% | — |
| Peers | +1.6% | +5.3% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 16 | — |
